National Health Investors INC Form 4 insider transactions

CEO D. Eric Mendelsohn acquired shares of National Health Investors through the exercise of stock options, with shares withheld to cover the exercise price and taxes.

Director Robert T. Webb exercises stock options and adjusts holdings within family trusts, according to a recent SEC filing.

John L. Spaid, CFO of National Health Investors, exercised stock options and disposed of shares to cover the exercise price and taxes on September 3, 2024.

John L. Spaid, CFO of National Health Investors, exercised stock options and disposed of shares to cover the exercise price and taxes on August 23, 2024.

Kevin Carlton Pascoe, Chief Investment Officer of National Health Investors Inc., exercised stock options on August 23, 2024, resulting in the acquisition and disposition of common stock.

David L. Travis, SVP/Chief Accounting Officer of National Health Investors, exercised stock options and disposed of shares to cover the exercise price and taxes on August 23, 2024.

Director Jobe James R. exercised stock options and disposed of shares of National Health Investors Inc. on August 23, 2024.

Director Tracy M J Colden exercised stock options and disposed of shares of National Health Investors Inc. on August 16, 2024.

Director Robert A. McCabe Jr. exercised stock options and disposed of shares of National Health Investors Inc. on July 29, 2024.

John L. Spaid, CFO of National Health Investors, disposed of 230 shares of common stock to cover tax obligations upon vesting.

Director Robert A. McCabe Jr. of National Health Investors Inc. (NHI) purchased 437 shares of common stock at $65.8312 per share on May 31, 2024.

Charlotte A. Swafford, a director at National Health Investors, Inc., purchased 10,000 shares of common stock at a price of $58.6882 per share on February 27, 2024.

David L. Travis, SVP/Chief Accounting Officer of National Health Investors, acquired 3,000 shares of common stock and multiple tranches of stock options on February 23, 2024.

John L. Spaid, CFO of National Health Investors, acquired 3,000 shares of common stock and multiple tranches of stock options on February 23, 2024.

Kevin Carlton Pascoe, Chief Investment Officer of National Health Investors Inc., reports acquisition of common stock and stock options.

Kristin Sallee Gaines, SVP/Chief Transaction Officer of National Health Investors, reports the acquisition of 3,000 shares of common stock and multiple stock option grants.

D. Eric Mendelsohn, CEO and President of National Health Investors, acquired 3,000 shares of common stock and multiple tranches of stock options on February 23, 2024.

Director Robert T. Webb reports acquisition of stock options and updates to beneficial ownership of National Health Investors Inc. (NHI) common stock.

Director Charlotte A. Swafford acquired 10,000 stock options and transferred 100,185 shares to a trust, according to a recent SEC filing.

Director Robert A. McCabe Jr. reports acquisition of stock options and shares in National Health Investors through a recent transaction and dividend reinvestment.

Director James R. Jobe reports the acquisition of stock options and disposals of common stock held jointly with spouse and in an IRA SEP.

Director Tracy M J Colden reports acquisition of stock options in National Health Investors Inc.

Director Robert G. Adams reports acquisition of stock options in National Health Investors, Inc.

Director W. Andrew Adams reports acquisition of 10,000 stock options in National Health Investors Inc. on February 23, 2024.